# A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation

Study · id `cardio:ct-nct06460831` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06460831](<https://clinicaltrials.gov/study/NCT06460831>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06460831

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT06460831. Randomized; double masking; primary purpose treatment. Start 2024-06-15 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT06460831, source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)
- Planned start: 2024-06-15 (anticipated) (ClinicalTrials.gov record NCT06460831, source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT06460831, source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)
- Completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT06460831, source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06460831, source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06460831-2024-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Intervention (Device): Microcatheter
- Intervention (Device): OTW
- Lead sponsor: Shanghai Chest Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: Shanghai Chest Hospital (`cardio:org-shanghai-chest-hospital`)

## Provenance

Content hash: e879e7bbb926069bd08d2ad72c41cb5e534be3c2d99f3d54e172cbe80987d5fa
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
